Fungal Keratitis
📧 Sign up to get email alerts when something new happens for Fungal Keratitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-30Clinical Trial Update: Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction [Phase 3]
Phase 3 clinical trial evaluating Rose Bengal with green light for infection reduction in Acanthamoeba keratitis and fungal keratitis has co…
-
FDA approval · 2025-11-17FDA Approved: NATACYN — Supplemental Application (Harrow Eye, LLC)
The FDA approved a supplemental application for NATACYN (natamycin) submitted by Harrow Eye, LLC.
-
CLINICAL_TRIALS other · 2025-10-15Clinical Trial Update: Trial to Evaluate the Efficacy And Safety of IVIEW-1201 In the Treatment of Fungal Keratitis [Phase 2]
A Phase 2 clinical trial evaluating IVIEW-1201 for fungal keratitis is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: Fungal Ulcer Treatment Augmented With Natamycin and Cyclosporine A [Phase 3]
An ongoing Phase 3 clinical trial is evaluating the combination of natamycin and cyclosporine A for fungal keratitis and corneal ulcers.
-
CLINICAL_TRIALS trial_result · 2024-08-27Clinical Trial Update: Cross-linking for Corneal Ulcers Treatment Trial [Phase 3]
A Phase 3 trial evaluating cross-linking therapy for corneal ulcers completed, with results posted on 2024-08-27. The sponsor was University…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-10-01Clinical Trial Update: Mycotic Antimicrobial Localized Injection for Treatment of Corneal Ulcers [Phase 3]
Phase 3 trial results for a mycotic antimicrobial localized injection in corneal ulcers (fungal keratitis) have been completed. Results were…
-
CLINICAL_TRIALS research · 2017-07-26Clinical Trial Update: Combination Treatment of 5% Natamycin and 1% Voriconazole in Fungal Keratitis [Phase 2, Phase 3]
A clinical trial update for a combination therapy of natamycin and voriconazole in fungal keratitis, spanning Phase 2 and Phase 3, with stat…
-
CLINICAL_TRIALS trial_result · 2017-06-01Clinical Trial Update: Safety and Efficacity of Corneal Collagen Crosslinking in Infectious Keratitis (Bacterial and Fungal ): Randomized,Controlled, Prospective Study. (CXL) [NA]
A randomized, controlled, prospective trial evaluating corneal collagen crosslinking for infectious keratitis (bacterial and fungal) was ter…
-
CLINICAL_TRIALS other · 2017-05-03Clinical Trial Update: UVX as an Adjuvant in the Treatment of Fungal Keratitis [NA]
Clinical trial update indicates UVX used as an adjuvant in the treatment of fungal keratitis, with the trial status currently unknown.
-
CLINICAL_TRIALS trial_result · 2015-05-04Clinical Trial Update: Collagen Cross-linking in Infectious Keratitis Trial [Phase 2]
A Phase 2 clinical trial evaluating collagen cross-linking for infectious keratitis has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: Clinical & Visual Outcomes of Collagen Cross Linking for Fungal Keratitis [NA]
An update on a clinical trial evaluating collagen cross-linking for fungal keratitis, reporting clinical and visual outcomes. The current st…
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: A Clinical Trial of the Treatment of Fungal Corneal Ulcers With Povidone-Iodine [Phase 3]
Phase 3 trial evaluating povidone-iodine for fungal keratitis was terminated.
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Therapeutic Exploratory Study of Comparing Natamycin and Voriconazole to Treat Fungal Corneal Ulcer [Phase 1, Phase 2]
Phase 1/2 trial exploring natamycin vs voriconazole for fungal keratitis completed with results posted in 2013.
-
FDA approval · 2008-07-18FDA Approved: NATACYN — Supplemental Application (Harrow Eye, LLC)
FDA approved a supplemental application for NATACYN (natamycin) from Harrow Eye, LLC. The action updates the regulatory status of NATACYN vi…